Effect of multidimensional Ayurvedic management of type II Diabetes mellitus (Madhumeha): single group pre - post design clinical study
Trial Snapshot
- Phase
- Phase 3 4
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 30
- Locations
- 1
Study Overview
Brief Summary
The management of Type 2 Diabetes Mellitus in conventional medicine primarily includes long-term use of oral hypoglycemic agents and insulin therapy due to the chronic, progressive, and relapsing nature of the disease. Prolonged administration of these therapies is often associated with adverse effects such as hypoglycemia, weight gain, gastrointestinal disturbances, and organ-related complications. Therefore, there is a growing need to explore alternative treatment approaches that can provide effective glycemic control while reducing long-term drug-related adverse effects. In individuals with Type 2 Diabetes Mellitus, a wide spectrum of clinical features and metabolic abnormalities may manifest at different stages of the disease. Hence, considering the multifactorial pathogenesis and variable clinical presentation, the present study has adopted a multi-dimensional Ayurvedic management approach to evaluate its impact on patients with Type 2 Diabetes Mellitus.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Masking
- None
Eligibility Criteria
- Ages
- 18.00 Year(s) to 70.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •1.Patients between the age group of eighteen to seventy years of both genders will be selected.
- •2.Patients with fasting blood sugar from one hundred twenty six milligrams per deciliter or postprandial blood sugar from two hundred milligrams per deciliter, with HbA1C level more than six point five percent.
Exclusion Criteria
- •1.Female patients who are pregnant or in the lactating period.
- •2.Patients aged less than eighteen years and more than seventy years.
- •3.Patients with HbA1C level more than eight point five percent.
- •4.Insulin dependent patients.
- •5.Patients with genetic syndromes associated with type two diabetes mellitus such as Down syndrome, Klinefelter syndrome, and Turner syndrome.
- •6.Patients having complications of diabetes such as nephropathy, neuropathy, retinopathy, carbuncles, and related conditions.
- •7.Patients with associated diseases that affect the outcome or completion of the treatment, such as cardiovascular disorders, autoimmune disorders, diabetic foot ulcer or gangrene, cancer, and kidney or liver disorders.
Investigators
Dr Krupali Patel
J S Ayurveda Mahavidyalaya and P D Patel Ayurveda Hospital